Outbreak of MRSA in a Gynecology/Obstetrics Department during the COVID-19 Pandemic: A Cautionary Tale

Since March 2020, the COVID-19 pandemic forced hospitals worldwide to intensify their infection control measures to prevent health care-associated transmission of SARS-CoV-2. The correct use of personal protective equipment, especially the application of masks, was quickly identified as priority to reduce transmission with this pathogen. Here, we report a nosocomial cluster of methicillin-resistant Staphylococcus aureus (MRSA) that occurred during the COVID-19 pandemic in a gynecology/obstetrics department, despite these intensified contact precautions. Five MRSA originating from clinical samples after surgical intervention led to an outbreak investigation. Firstly, this included environmental sampling of the operation theatre (OT) and, secondly, a point prevalence screening of patients and health care workers (HCW). All detected MRSA were subjected to whole genome sequencing (WGS) and isolate relatedness was determined using core genome multilocus sequence typing (cgMLST). WGS revealed one MRSA cluster with genetically closely related five patient and two HCW isolates differing in a single cgMLST allele at maximum. The outbreak was terminated after implementation of infection control bundle strategies. Although contact precaution measures, which are also part of MRSA prevention bundle strategies, were intensified during the COVID-19 pandemic, this MRSA outbreak could take place. This illustrates the importance of adherence to classical infection prevention strategies.

[1]  M. Schlegel,et al.  The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature , 2022, Antimicrobial resistance and infection control.

[2]  L. Saiman,et al.  COVID-19 Infection, Prevention, and Control Considerations in the Obstetric Environment , 2021, Clinical obstetrics and gynecology.

[3]  Robert P. Lennon,et al.  Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil , 2021, American Journal of Infection Control.

[4]  M. Diercke,et al.  Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020 , 2021, The Lancet regional health. Europe.

[5]  K. Yahara,et al.  Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance , 2021, Journal of Hospital Infection.

[6]  W. Ko,et al.  Increased antimicrobial resistance during the COVID-19 pandemic , 2021, International Journal of Antimicrobial Agents.

[7]  P. Luethy,et al.  Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units , 2021, Emerging infectious diseases.

[8]  M. Simmaco,et al.  Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study , 2021, International journal of environmental research and public health.

[9]  L. Wee,et al.  Unintended consequences of infection prevention and control measures during COVID-19 pandemic , 2020, American Journal of Infection Control.

[10]  J. Cole,et al.  The impact of the COVID-19 pandemic on healthcare acquired infections with multidrug resistant organisms , 2020, American Journal of Infection Control.

[11]  A. Mellmann,et al.  A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit , 2020, Antimicrobial Resistance and Infection Control.

[12]  S. Barnini,et al.  Increased Risk of Acquisition of New Delhi Metallo-Beta-Lactamase-Producing Carbapenem-Resistant Enterobacterales (NDM-CRE) among a Cohort of COVID-19 Patients in a Teaching Hospital in Tuscany, Italy , 2020, Pathogens.

[13]  Alexandre Souvorov,et al.  SKESA: strategic k-mer extension for scrupulous assemblies , 2018, Genome Biology.

[14]  A. Mellmann,et al.  Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting , 2016, Journal of Clinical Microbiology.

[15]  C. Linden,et al.  Environmental survival of vancomycin-sensitive ampicillin-resistant Enterococcus faecium (AREfm) , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  C. Ruscher Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen , 2014, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[17]  Dag Harmsen,et al.  Bacterial Whole-Genome Sequencing Revisited: Portable, Scalable, and Standardized Analysis for Typing and Detection of Virulence and Antibiotic Resistance Genes , 2014, Journal of Clinical Microbiology.

[18]  J. Sheffield Methicillin-Resistant Staphylococcus aureus in Obstetrics , 2013, American Journal of Perinatology.

[19]  P. Gastmeier,et al.  Decreasing healthcare-associated infections (HAI) is an efficient method to decrease healthcare-associated Methicillin-resistant S.aureus (MRSA) infections Antimicrobial resistance data from the German national nosocomial surveillance system KISS , 2012, Antimicrobial Resistance and Infection Control.

[20]  C. Gomersall,et al.  Increase in Methicillin-Resistant Staphylococcus aureus Acquisition Rate and Change in Pathogen Pattern Associated with an Outbreak of Severe Acute Respiratory Syndrome , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  D. Flaxman,et al.  The usefulness of masks in preventing transient carriage of epidemic methicillin-resistant Staphylococcus aureus by healthcare workers. , 2001, The Journal of hospital infection.

[22]  Alice N. Neely,et al.  Survival of Enterococci and Staphylococci on Hospital Fabrics and Plastic , 2000, Journal of Clinical Microbiology.